Patent ID: 9675672
Date: 2017-06-13
CPC Classifications: A61K,A61P,A61Q,C07K

Claim:
1. A pharmaceutical composition comprising: a therapeutically effective amount of a peptide conjugate, or a derivative thereof; and a pharmaceutically acceptable carrier, diluent, excipient or combination thereof; wherein the peptide conjugate or derivative thereof comprises amino acid sequences of at least two interleukin (IL) protein gamma-c-box D-helix regions; wherein the peptide conjugate or derivative thereof inhibits the activity of two or more γc-cytokines selected from the group consisting of: IL-2, IL-4, IL-7, IL-9, IL-15 or IL-21; wherein the peptide conjugate comprises the amino acid sequence D/E-F-L-E/Q/N-S/R-X-I/K-X-L/I-X-Q (SEQ ID NO: 2), X representing any amino acid; wherein the derivative comprises a peptide sequence sharing at least 90% identity with the amino acid sequence of SEQ ID NO: 2.